APOE and Alzheimer disease: Specifically, of all 20 AD risk SNPs under study, the effect size of ABCA7 was the highest after APOE. Further analysis revealed that the effect of ABCA7 on amyloidosis was significant in the cognitively healthy and MCI individuals, but not in the AD group, suggesting an early effect of ABCA7 [46].